Human Genome Sciences

There are two companies apart from Glaxo that are in the process of discussion to make a bid for Human Genome according to reports from sources who are familiar with the situation. Among them Celgene is at a preferable position if it at all makes a bid. As per the source who talked on condition of anonymity stated that it would be more or less a merger of equals situation even though he did not quite identify the other bidder.